TechnologyHealth-Tech Startup Evidation Opens Up Its Symptom-Logging App To...

Health-Tech Startup Evidation Opens Up Its Symptom-Logging App To Track Migraine Discomfort

-

California health technology firm Evidation is making its app for logging symptoms more open to track how migraine symptoms. MigraineSmart, which is a part of Evidation’s app, gathers patient-generated data in addition to survey results and activity monitoring from wearable devices.

This combination is hoped to provide insight into whether there is a correlation between these factors and migraines.

People can be encouraged to complete the surveys through the proximal rewards in the form of points and in turn, more information, such as pharmacy claims and electronic health records can be acquired for further understanding of normal migraine treatments.

An initial pilot study of the MigraineSmart program, involving 3,492 participants, revealed the following findings:

– In terms of treatment, participants were asked what medications they took for their symptoms and 43% of them reported to have used prescription drugs. Triptans topped the list of medications used.
– From the migraines days to the other days, the participants were found to be moving an average of 50% less per day.
– More than half of the participants admitted that they have shared or would share their monthly MigraineSmart report with their physicians.

MigraineSmart is a multi-component platform that includes survey information as well as ePRO, wearables, and evidence-based content in the Evidation app.

In another survey of a considerably higher population of 21,707 people, more than 40% reported having not sought professional healthcare for the ailment in the previous year.

The pilot research also supported the hypothesis and the participants provided data that they are less physically active and took only half of the usual steps when they had a migraine. Migraines can be a chronic condition, and it is estimated that over 40 million people in the United States have been diagnosed with it.

Migraine is a recurrent and painful type of headache, which more than 40 million Americans experience- women are more vulnerable to this condition as compared to men. These headaches can, therefore, cause a good deal of discomfort, affecting physical and mental health, work productivity, and social interactions. As far as the factors concerning migraines, they are believed to be caused by genetic, environmental, and other factors.

99d6180bd0b633b26e2da11082fdc6153eded9e22ef1cbe1db9f0d81c8fb5368?s=150&d=mp&r=g
+ posts

Latest news

Gilead Secures Arenavirus Vaccine Programs from Hookipa for $10 Million

Gilead Sciences has acquired exclusive ownership of two arenavirus-based immunotherapy programs for hepatitis B (HBV) and human immunodeficiency virus...

Sanofi Acquires Vigil Neuroscience for $470M to Boost Alzheimer’s Drug Pipeline

Sanofi is acquiring Vigil Neuroscience for $470 million to expand its Alzheimer’s drug portfolio, focusing on TREM2-targeting therapies like...

Moderna Delays Flu-COVID Combo Vaccine Filing Amid FDA Request

Moderna has announced that it is withdrawing its application for approval from the U.S. Food and Drug Administration (FDA)...

Must read

Surrounded by controversy, FDA approves Biogen’s Alzheimer’s drug Aduhelm

In the middle of the debate about the Alzheimer’s drug approval, the United States FDA has authorized Aduhelm

You might also likeRELATED
Recommended to you